Literature DB >> 6140942

The effects of astemizole on antipyrine clearance.

D N Bateman, M D Rawlins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6140942      PMCID: PMC1428349          DOI: 10.1111/j.1365-2125.1983.tb02262.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  Assessment of antipyrine kinetics by measurement in saliva.

Authors:  H S Fraser; J C Mucklow; S Murray; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

2.  Measurement of urinary 6-beta-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin.

Authors:  E E Ohnhaus; B K Park
Journal:  Eur J Clin Pharmacol       Date:  1979-03-26       Impact factor: 2.953

Review 3.  Clinical implications of enzyme induction and enzyme inhibition.

Authors:  B K Park; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1981 Jan-Feb       Impact factor: 6.447

4.  Interindividual differences in rates of drug oxidation in man.

Authors:  D S Davies; S S Thorgeirsson; A Breckenridge; M Orme
Journal:  Drug Metab Dispos       Date:  1973 Jan-Feb       Impact factor: 3.922

5.  Performance studies with the H1-histamine receptor antagonists, astemizole and terfenadine.

Authors:  A N Nicholson; B M Stone
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

  5 in total
  3 in total

1.  Cisapride has no effect on antipyrine clearance.

Authors:  D S Davies; F J Mills; P J Welburn
Journal:  Br J Clin Pharmacol       Date:  1988-12       Impact factor: 4.335

Review 2.  Pharmacokinetic optimisation of histamine H1-receptor antagonist therapy.

Authors:  F E Simons; K J Simons
Journal:  Clin Pharmacokinet       Date:  1991-11       Impact factor: 6.447

Review 3.  Astemizole. A review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  D M Richards; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-07       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.